Skip to main content
. 2022 Jun 25;2022:2916223. doi: 10.1155/2022/2916223

Table 4.

Incidence rate of adverse reactions in two groups.

Group Number of cases Adverse reactions Normal P
Study 33 2 (6.06%) 31 (93.94%) 0.512
Control 32 1 (3.12%) 31 (96.88%)